Related Experiment Video
Updated: Aug 4, 2026

High-throughput Assay to Phenotype Salmonella enterica Typhimurium Association, Invasion, and Replication in Macrophages
Published on: August 12, 2014
[Multidrug-resistant and fluoroquinolone-resistant Salmonella enterica serotype Typhimurium definitive phage type 12
H Nakaya1, A Yasuhara, K Yoshimura
1Department of Clinical Center Laboratory, Kansai Medical University.
Abstract:
A 35-day-old male infant was admitted to our hospital, presenting a high fever, vomiting, and diarrhea. Multidrug-resistant and fluoroquinolon-resistant Salmonella serotype Typhimurium was isolated from his stool. The phage type of the strain was DT12. The strain was resistant to ampicillin, streptomycin, gentamicin, tetracycline, chloramphenicol, sulfamethoxazole-trimethoprim, and fluoroquinolones (levofloxacin; MIC 8 micrograms/ml, norfloxacin; 24 micrograms/ml, ciprofloxacin; 16 micrograms/ml, sparfloxacin; 32 micrograms/ml). He was cured by antibiotic therapy using fosfomycin (< or = 1 microgram/ml). We could not determine a route of infection. Domestic surveillance for fluoroquinolon-resistant Sallmonella is necessary.
Insights
A multidrug-resistant Salmonella Typhimurium strain resistant to fluoroquinolones caused severe infant illness. Fosfomycin successfully treated the infection, highlighting the need for surveillance of resistant Salmonella strains.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Salmonella serotype Typhimurium is a common cause of bacterial gastroenteritis.
- The emergence of antimicrobial resistance in Salmonella poses a significant public health threat.
- Fluoroquinolones are critical antibiotics for treating invasive Salmonella infections.
Observation:
- A 35-day-old infant presented with severe symptoms including high fever, vomiting, and diarrhea.
- Stool cultures identified a multidrug-resistant Salmonella serotype Typhimurium (phage type DT12).
- The isolate exhibited resistance to multiple antibiotics, including all tested fluoroquinolones.
Findings:
- The infant's infection was successfully treated with fosfomycin (MIC <= 1 microgram/ml).
- The specific route of infection could not be determined.
- This case highlights the challenge of treating infections caused by extensively drug-resistant bacteria.
Implications:
- Fosfomycin demonstrates efficacy against fluoroquinolone-resistant Salmonella Typhimurium.
- Enhanced domestic surveillance for fluoroquinolone-resistant Salmonella is crucial.
- This case underscores the importance of antimicrobial stewardship and monitoring resistance patterns.
Related Concept Videos
DNA Bacteriophages
Bacterial Gastroenteritis
Cholera

